Cargando…
Altered Nrf2 Signaling Mediates Hypoglycemia-Induced Blood–Brain Barrier Endothelial Dysfunction In Vitro
Hypoglycemia impairs blood-brain barrier (BBB) endothelial function; a major hallmark in the pathogenesis of various CNS disorders. Previously, we have demonstrated that prolonged hypoglycemic exposure down-regulated BBB endothelial NF-E2 related factor-2 (Nrf2) expression; a redox-sensitive transcr...
Autores principales: | Sajja, Ravi K., Green, Kayla N., Cucullo, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373930/ https://www.ncbi.nlm.nih.gov/pubmed/25807533 http://dx.doi.org/10.1371/journal.pone.0122358 |
Ejemplares similares
-
Proximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to Neurodegeneration
por: Festoff, Barry W., et al.
Publicado: (2017) -
Impact of altered glycaemia on blood-brain barrier endothelium: an in vitro study using the hCMEC/D3 cell line
por: Sajja, Ravi K, et al.
Publicado: (2014) -
In vitro characterization of odorranalectin for peptide-based drug delivery across the blood–brain barrier
por: Sajja, Ravi K., et al.
Publicado: (2019) -
HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease
por: Festoff, Barry W., et al.
Publicado: (2016) -
Impact of cigarette smoke extract and hyperglycemic conditions on blood–brain barrier endothelial cells
por: Prasad, Shikha, et al.
Publicado: (2015)